Live Webcast – Nov. 14-15 Workshop: International Commission on Clinical Use of Heritable Human Genome Editing
The International Commission on the Clinical Use of Human Germline Genome Editing is convening a public workshop in London on Nov. 14-15. The commission will hear from invited experts in genetics, ethics, human health, and reproduction on a variety of topics, including alternatives to heritable genome editing and how applicable they are for certain inherited diseases, future technologies that might enable its clinical use should society consider that acceptable, and possible systems of governance and oversight.
The workshop is being hosted by the Royal Society of the U.K., which is serving as a secretariat to the commission, together with the U.S. National Academy of Medicine and the U.S. National Academy of Sciences. The commission is tasked with developing a framework for scientists, clinicians, and regulatory authorities to consider when assessing potential clinical applications of human germline genome editing. The framework could inform the development of a potential pathway from research to clinical use – if society concludes that heritable human genome editing applications are acceptable.
The workshop will take place in London from 9 a.m. to 5:15 p.m. GMT on Thursday, Nov. 14, at the National Gallery, Trafalgar Square, WC2N 5DN, and from 8:30 a.m. to noon GMT on Friday, Nov. 15, at the Royal Society, Carlton House Terrace, SW1Y 5AG. An agenda for the workshop is available here. The workshop will be webcast live via the Royal Society’s YouTube channel; archived video will also be available.
Seating is limited; journalists who wish to attend must register in advance with the Royal Society press office (contacts below).
More information on the commission, including its membership and statement of task, is available on the commission’s web page.
Alex Matthews-King / Bronwyn Friedlander
The Royal Society
+44 (0)207 451 2510 / 2514
Office of News and Public Information
U.S. National Academies of Sciences, Engineering, and Medicine
+1 202 334 2138